These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1130 related items for PubMed ID: 25551230

  • 1. Comparison of human induced pluripotent stem-cell derived cardiomyocytes with human mesenchymal stem cells following acute myocardial infarction.
    Citro L, Naidu S, Hassan F, Kuppusamy ML, Kuppusamy P, Angelos MG, Khan M.
    PLoS One; 2014; 9(12):e116281. PubMed ID: 25551230
    [Abstract] [Full Text] [Related]

  • 2. Immunomodulation by systemic administration of human-induced pluripotent stem cell-derived mesenchymal stromal cells to enhance the therapeutic efficacy of cell-based therapy for treatment of myocardial infarction.
    Sun SJ, Lai WH, Jiang Y, Zhen Z, Wei R, Lian Q, Liao SY, Tse HF.
    Theranostics; 2021; 11(4):1641-1654. PubMed ID: 33408772
    [Abstract] [Full Text] [Related]

  • 3. Thymosin β4 increases cardiac cell proliferation, cell engraftment, and the reparative potency of human induced-pluripotent stem cell-derived cardiomyocytes in a porcine model of acute myocardial infarction.
    Tan SH, Loo SJ, Gao Y, Tao ZH, Su LP, Wang CX, Zhang SL, Mu YH, Cui YH, Abdurrachim D, Wang WH, Lalic J, Lim KC, Bu J, Tan RS, Lee TH, Zhang J, Ye L.
    Theranostics; 2021; 11(16):7879-7895. PubMed ID: 34335970
    [Abstract] [Full Text] [Related]

  • 4. Thioredoxin-1 (Trx1) engineered mesenchymal stem cell therapy increased pro-angiogenic factors, reduced fibrosis and improved heart function in the infarcted rat myocardium.
    Suresh SC, Selvaraju V, Thirunavukkarasu M, Goldman JW, Husain A, Alexander Palesty J, Sanchez JA, McFadden DW, Maulik N.
    Int J Cardiol; 2015 Dec 15; 201():517-28. PubMed ID: 26322599
    [Abstract] [Full Text] [Related]

  • 5. Myocardial repair of bioengineered cardiac patches with decellularized placental scaffold and human-induced pluripotent stem cells in a rat model of myocardial infarction.
    Jiang Y, Sun SJ, Zhen Z, Wei R, Zhang N, Liao SY, Tse HF.
    Stem Cell Res Ther; 2021 Jan 07; 12(1):13. PubMed ID: 33413626
    [Abstract] [Full Text] [Related]

  • 6. CCND2 Overexpression Enhances the Regenerative Potency of Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes: Remuscularization of Injured Ventricle.
    Zhu W, Zhao M, Mattapally S, Chen S, Zhang J.
    Circ Res; 2018 Jan 05; 122(1):88-96. PubMed ID: 29018036
    [Abstract] [Full Text] [Related]

  • 7. Microfluidic Single-Cell Analysis of Transplanted Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes After Acute Myocardial Infarction.
    Ong SG, Huber BC, Lee WH, Kodo K, Ebert AD, Ma Y, Nguyen PK, Diecke S, Chen WY, Wu JC.
    Circulation; 2015 Aug 25; 132(8):762-771. PubMed ID: 26304668
    [Abstract] [Full Text] [Related]

  • 8. Evaluation of Changes in Morphology and Function of Human Induced Pluripotent Stem Cell Derived Cardiomyocytes (HiPSC-CMs) Cultured on an Aligned-Nanofiber Cardiac Patch.
    Khan M, Xu Y, Hua S, Johnson J, Belevych A, Janssen PM, Gyorke S, Guan J, Angelos MG.
    PLoS One; 2015 Aug 25; 10(5):e0126338. PubMed ID: 25993466
    [Abstract] [Full Text] [Related]

  • 9. Potent immunomodulation and angiogenic effects of mesenchymal stem cells versus cardiomyocytes derived from pluripotent stem cells for treatment of heart failure.
    Liao S, Zhang Y, Ting S, Zhen Z, Luo F, Zhu Z, Jiang Y, Sun S, Lai WH, Lian Q, Tse HF.
    Stem Cell Res Ther; 2019 Mar 07; 10(1):78. PubMed ID: 30845990
    [Abstract] [Full Text] [Related]

  • 10. Functional Effects of a Tissue-Engineered Cardiac Patch From Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes in a Rat Infarct Model.
    Wendel JS, Ye L, Tao R, Zhang J, Zhang J, Kamp TJ, Tranquillo RT.
    Stem Cells Transl Med; 2015 Nov 07; 4(11):1324-32. PubMed ID: 26371342
    [Abstract] [Full Text] [Related]

  • 11. Combined Treatment of Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes and Endothelial Cells Regenerate the Infarcted Heart in Mice and Non-Human Primates.
    Cheng YC, Hsieh ML, Lin CJ, Chang CMC, Huang CY, Puntney R, Wu Moy A, Ting CY, Herr Chan DZ, Nicholson MW, Lin PJ, Chen HC, Kim GC, Zhang J, Coonen J, Basu P, Simmons HA, Liu YW, Hacker TA, Kamp TJ, Hsieh PCH.
    Circulation; 2023 Oct 31; 148(18):1395-1409. PubMed ID: 37732466
    [Abstract] [Full Text] [Related]

  • 12. CHIR99021 and fibroblast growth factor 1 enhance the regenerative potency of human cardiac muscle patch after myocardial infarction in mice.
    Fan C, Tang Y, Zhao M, Lou X, Pretorius D, Menasche P, Zhu W, Zhang J.
    J Mol Cell Cardiol; 2020 Apr 31; 141():1-10. PubMed ID: 32169551
    [Abstract] [Full Text] [Related]

  • 13. Transplantation of human induced pluripotent stem cell-derived cardiomyocytes improves myocardial function and reverses ventricular remodeling in infarcted rat hearts.
    Guan X, Xu W, Zhang H, Wang Q, Yu J, Zhang R, Chen Y, Xia Y, Wang J, Wang D.
    Stem Cell Res Ther; 2020 Feb 21; 11(1):73. PubMed ID: 32085809
    [Abstract] [Full Text] [Related]

  • 14. N-cadherin overexpression enhances the reparative potency of human-induced pluripotent stem cell-derived cardiac myocytes in infarcted mouse hearts.
    Lou X, Zhao M, Fan C, Fast VG, Valarmathi MT, Zhu W, Zhang J.
    Cardiovasc Res; 2020 Mar 01; 116(3):671-685. PubMed ID: 31350544
    [Abstract] [Full Text] [Related]

  • 15. Cardiomyocytes from CCND2-overexpressing human induced-pluripotent stem cells repopulate the myocardial scar in mice: A 6-month study.
    Fan C, Fast VG, Tang Y, Zhao M, Turner JF, Krishnamurthy P, Rogers JM, Valarmathi MT, Yang J, Zhu W, Zhang J.
    J Mol Cell Cardiol; 2019 Dec 01; 137():25-33. PubMed ID: 31629738
    [Abstract] [Full Text] [Related]

  • 16. Magnesium lithospermate B enhances the potential of human-induced pluripotent stem cell-derived cardiomyocytes for myocardial repair.
    Fan C, Qin K, Iroegbu CD, Xiang K, Gong Y, Guan Q, Wang W, Peng J, Guo J, Wu X, Yang J.
    Chin Med J (Engl); 2024 Aug 05; 137(15):1857-1869. PubMed ID: 38221772
    [Abstract] [Full Text] [Related]

  • 17. Dual stem cell therapy synergistically improves cardiac function and vascular regeneration following myocardial infarction.
    Park SJ, Kim RY, Park BW, Lee S, Choi SW, Park JH, Choi JJ, Kim SW, Jang J, Cho DW, Chung HM, Moon SH, Ban K, Park HJ.
    Nat Commun; 2019 Jul 16; 10(1):3123. PubMed ID: 31311935
    [Abstract] [Full Text] [Related]

  • 18. Functional and Electrical Integration of Induced Pluripotent Stem Cell-Derived Cardiomyocytes in a Myocardial Infarction Rat Heart.
    Higuchi T, Miyagawa S, Pearson JT, Fukushima S, Saito A, Tsuchimochi H, Sonobe T, Fujii Y, Yagi N, Astolfo A, Shirai M, Sawa Y.
    Cell Transplant; 2015 Jul 16; 24(12):2479-89. PubMed ID: 25606821
    [Abstract] [Full Text] [Related]

  • 19. AKT-modified autologous intracoronary mesenchymal stem cells prevent remodeling and repair in swine infarcted myocardium.
    Yu YS, Shen ZY, Ye WX, Huang HY, Hua F, Chen YH, Chen K, Lao WJ, Tao L.
    Chin Med J (Engl); 2010 Jul 16; 123(13):1702-8. PubMed ID: 20819633
    [Abstract] [Full Text] [Related]

  • 20. Angiopoietin-1 enhanced myocyte mitosis, engraftment, and the reparability of hiPSC-CMs for treatment of myocardial infarction.
    Tao Z, Loo S, Su L, Tan S, Tee G, Gan SU, Zhang J, Chen X, Ye L.
    Cardiovasc Res; 2021 May 25; 117(6):1578-1591. PubMed ID: 32666104
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 57.